{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:58:31Z","timestamp":1793717911365,"version":"4.6.1"},"reference-count":41,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T00:00:00Z","timestamp":1178236800000},"content-version":"vor","delay-in-days":3076,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> IL\u20101 receptor antagonist (IL\u20101ra) is a cytokine that competitively binds the IL\u20101 receptor to antagonize IL\u20101 activity without any agonist function. Previous experiments indicated that the ratio of IL\u20101ra to IL\u20101\u03b1 in the normal stratum corneum (SC) was much higher in the sunexposed face than in the sun\u2010protected area, upper arms. It was also reported by another laboratory that IL\u20101ra is increased in the lesional skin of psoriatic patients. This study was designed to measure the contents of IL\u20101\u03b1 and IL\u20101ra in non\u2010lesional and pathological SC obtained from inflammatory skin diseases including psoriasis and non\u2010psoriatic dermatoses such as atopic dermatitis. The SC materials were obtained with a noninvasive tape\u2010stripping method. Their soluble fractions were prepared and assayed for IL\u20101\u03b1 and IL\u20101ra by enzyme\u2010linked immunosorbent assays. As a result we confirmed the previous findings that the ratio of IL\u20101ra to IL\u20101\u03b1 in the normal SC was much higher in the face than in the sun\u2010protected sites, the trunk as well as extremities. Next, we found that IL\u20101\u03b1 contents were significantly reduced in the SC samples obtained from inflammatory skin regardless of whether their IL\u20101ra contents increased or unchanged. Moreover, we noted that an increased ratio of IL\u20101ra to IL\u20101\u03b1 in the SC was not specific to psoriasis, but was also found in other inflammatory skin diseases including atopic dermatitis. This ratio was found to become lower after successful treatment of these skin lesions with topical glucocorticoids. We conclude from these observations that the increased ratio of IL\u20101ra to IL\u20101\u03b1 in the SC is a non\u2010specific phenomenon that can occur in any inflammatory skin diseases regardless of the inflammatory pattern, probably reflecting a skin regulation process against various kinds of inflammation.<\/jats:p>","DOI":"10.1111\/j.1600-0625.1998.tb00332.x","type":"journal-article","created":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T14:11:21Z","timestamp":1178287881000},"page":"327-334","source":"Crossref","is-referenced-by-count":78,"title":["An increased ratio of interleukin\u20101 receptor antagonist to interleukin\u20101\u03b1 in inflammatory skin diseases"],"prefix":"10.1111","volume":"7","author":[{"given":"T.","family":"Terui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Uesugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kudoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,5,4]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/343341a0"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood.V77.8.1627.1627","article-title":"Blocking IL\u20101: interleukin 1 and interleukin\u20101 antagonism","volume":"77","author":"Dinarello C A.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.9.3681"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12494196"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(91)81360-K"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12285633"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.164.6.2095"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112141"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000249347"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.156.149"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12876130"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)99230-6"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)98655-2"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12284068"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115896"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00446.x"},{"key":"e_1_2_1_18_2","first-page":"268","article-title":"Local increase in interleukin\u20101\u2010like activity following UVB irradiation of human skin in vivo","volume":"6","author":"Murphy G M.","year":"1989","journal-title":"Photodermatology"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12614470"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12340143"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(96)00572-5"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb08190.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.4049\/jimmunol.144.12.4593","article-title":"IL\u20101 activity is reduced in psoriatic skin: decreased IL\u20101\u03b1 and increased nonfunctional IL\u20101\u03b2","volume":"144","author":"Cooper K D.","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115067"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270908"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.158.6.2955"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.4049\/jimmunol.150.9.4008","article-title":"Regulation of expression of IL\u20101 receptor antagonist protein in human synovial and dermal fibroblasts","volume":"150","author":"Krzesicki R F.","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.2.593"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.4049\/jimmunol.147.5.1530","article-title":"IL\u20101 receptor antagonist and IL\u20101\u03b2 production in human monocytes are regulated differently","volume":"147","author":"Arend W P.","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.4049\/jimmunol.147.12.4218","article-title":"Production of IL\u20101 receptor antagonist by human in vitro\u2010derived macrophages","volume":"147","author":"Janson R W.","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/1043-4666(92)90041-O"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.149.6.2000","article-title":"Human IL\u20101 receptor antagonist promoter: cell type\u2010specific activity and identification of regulatory regions","volume":"149","author":"Smith M F.","year":"1992","journal-title":"J Immunol"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.4049\/jimmunol.153.8.3584","article-title":"LPS\u2010induced expression of the human IL\u20101 receptor antagonist gene is controlled by multiple interacting promoter elements","volume":"153","author":"Smith M F.","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_35_2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4049\/jimmunol.153.2.701","article-title":"Comparison of two promoters controlling expression of secreted or intracellular IL\u20101 receptor antagonist","volume":"153","author":"Butcher C.","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.2.623"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830210708"},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4049\/jimmunol.149.3.925","article-title":"IL\u20104 up\u2010regulates IL\u20101 receptor antagonist gene expression and its production in human blood monocytes","volume":"149","author":"Orino E.","year":"1992","journal-title":"J Immunol"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.9.4076"},{"key":"e_1_2_1_40_2","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.4049\/jimmunol.150.10.4687","article-title":"Induction of circulating IL\u20101 receptor antagonist by IFN treatment","volume":"150","author":"Tilg H.","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.156.7.2503"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12360119"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0625.1998.tb00332.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0625.1998.tb00332.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T08:22:13Z","timestamp":1698481333000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0625.1998.tb00332.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1111\/j.1600-0625.1998.tb00332.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0625.1998.tb00332.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}